Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Identification of residues that underpin interactions within the eukaryotic initiation factor (eIF2) 2B complex.

Wang X, Wortham NC, Liu R, Proud CG.

J Biol Chem. 2012 Mar 9;287(11):8263-74. doi: 10.1074/jbc.M111.331553. Epub 2012 Jan 11.

2.

eIF2B: recent structural and functional insights into a key regulator of translation.

Wortham NC, Proud CG.

Biochem Soc Trans. 2015 Dec;43(6):1234-40. doi: 10.1042/BST20150164. Review.

PMID:
26614666
3.

The large spectrum of eIF2B-related diseases.

Fogli A, Boespflug-Tanguy O.

Biochem Soc Trans. 2006 Feb;34(Pt 1):22-9. Review.

PMID:
16246171
4.

A new function and complexity for protein translation initiation factor eIF2B.

Jennings MD, Pavitt GD.

Cell Cycle. 2014;13(17):2660-5. doi: 10.4161/15384101.2014.948797. Review.

5.

[Eukaryotic translation initiation factor 2B and leukoencephalopathy with vanishing white matter].

Pan YX, Wu Y, Niu ZP, Jiang YW.

Beijing Da Xue Xue Bao. 2009 Oct 18;41(5):608-10. Review. Chinese.

6.

eIF2B, a mediator of general and gene-specific translational control.

Pavitt GD.

Biochem Soc Trans. 2005 Dec;33(Pt 6):1487-92. Review.

PMID:
16246152
7.

Clues to the mechanism of action of eIF2B, the guanine-nucleotide-exchange factor for translation initiation.

Mohammad-Qureshi SS, Jennings MD, Pavitt GD.

Biochem Soc Trans. 2008 Aug;36(Pt 4):658-64. doi: 10.1042/BST0360658. Review.

PMID:
18631136
8.

Protein synthesis and its control in neuronal cells with a focus on vanishing white matter disease.

Pavitt GD, Proud CG.

Biochem Soc Trans. 2009 Dec;37(Pt 6):1298-310. doi: 10.1042/BST0371298. Review.

PMID:
19909266
9.

eIF2 and the control of cell physiology.

Proud CG.

Semin Cell Dev Biol. 2005 Feb;16(1):3-12. Epub 2004 Dec 10. Review.

PMID:
15659334
10.

Localization of the translational guanine nucleotide exchange factor eIF2B: a common theme for GEFs?

Campbell SG, Ashe MP.

Cell Cycle. 2006 Apr;5(7):678-80. Epub 2006 Apr 1. Review.

PMID:
16582624
11.

Leukoencephalopathy with vanishing white matter: a review.

Bugiani M, Boor I, Powers JM, Scheper GC, van der Knaap MS.

J Neuropathol Exp Neurol. 2010 Oct;69(10):987-96. doi: 10.1097/NEN.0b013e3181f2eafa. Review.

PMID:
20838246
12.

The spectrum of mutations for the diagnosis of vanishing white matter disease.

Scali O, Di Perri C, Federico A.

Neurol Sci. 2006 Sep;27(4):271-7. Review.

PMID:
16998732
13.

Regulation of eukaryotic initiation factor eIF2B.

Proud CG.

Prog Mol Subcell Biol. 2001;26:95-114. Review. No abstract available.

PMID:
11575168
14.

eIF2B and oligodendrocyte survival: where nature and nurture meet in bipolar disorder and schizophrenia?

Carter CJ.

Schizophr Bull. 2007 Nov;33(6):1343-53. Epub 2007 Feb 27. Review.

15.

Purification of FLAG-tagged eukaryotic initiation factor 2B complexes, subcomplexes, and fragments from Saccharomyces cerevisiae.

Mohammad-Qureshi SS, Haddad R, Palmer KS, Richardson JP, Gomez E, Pavitt GD.

Methods Enzymol. 2007;431:1-13. Review.

PMID:
17923227
16.

Leukoencephalopathy with vanishing white matter: from magnetic resonance imaging pattern to five genes.

Leegwater PA, Pronk JC, van der Knaap MS.

J Child Neurol. 2003 Sep;18(9):639-45. Review.

PMID:
14572143

Supplemental Content

Support Center